Cargando…

Humoral and cellular response in convalescent COVID-19 lupus patients

In SLE, underlying immune dysregulation and immunosuppression may increase the susceptibility to COVID-19 and impair the humoral and adaptive response. We aimed to characterize COVID-19 infection, identifying susceptibility and severity risk factors, assessing the presence of SARS-CoV-2 IgG antibodi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solé, Cristina, Domingo, Sandra, Vidal, Xavier, Cortés-Hernández, Josefina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374301/ https://www.ncbi.nlm.nih.gov/pubmed/35962159 http://dx.doi.org/10.1038/s41598-022-17334-5

Ejemplares similares

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
por: Zabalza, Ana, et al.
Publicado: (2022)

MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis
por: Domingo, Sandra, et al.
Publicado: (2020)

Thalidomide Exerts Anti-Inflammatory Effects in Cutaneous Lupus by Inhibiting the IRF4/NF-ҡB and AMPK1/mTOR Pathways
por: Domingo, Sandra, et al.
Publicado: (2021)

SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV()
por: Giannone, Denise, et al.
Publicado: (2022)

Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab
por: Adamec, Ivan, et al.
Publicado: (2022)

The Urinary Exosomal miRNA Expression Profile is Predictive of Clinical Response in Lupus Nephritis
por: Garcia-Vives, Eloi, et al.
Publicado: (2020)

An Exosomal Urinary miRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus Nephritis
por: Solé, Cristina, et al.
Publicado: (2019)

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
por: Ni, Ling, et al.
Publicado: (2020)

Comparing Humoral and Cellular Adaptive Immunity during Convalescent Phase of COVID-19 in Hemodialysis Patients and Kidney Transplant Recipients
por: Kamińska, Dorota, et al.
Publicado: (2021)

Humoral and cellular immunity in convalescent and vaccinated COVID-19 people with multiple sclerosis: Effects of disease modifying therapies
por: Habek, Mario, et al.
Publicado: (2022)

Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency
por: Honjo, Kazuhito, et al.
Publicado: (2020)

Urinary Neuropilin-1: A Predictive Biomarker for Renal Outcome in Lupus Nephritis
por: Torres-Salido, Maria Teresa, et al.
Publicado: (2019)

SARS-CoV-2 recombinant proteins stimulate distinct cellular and humoral immune response profiles in samples from COVID-19 convalescent patients
por: da Silva, Laís Teodoro, et al.
Publicado: (2021)

Humoral, Cellular and Cytokine Immune Responses Against SARS-CoV-2 Variants in COVID-19 Convalescent and Confirmed Patients With Different Disease Severities
por: Chiu, Chun-Hsiang, et al.
Publicado: (2022)

Interferon Lambda Regulates Cellular and Humoral Immunity in Pristane-Induced Lupus
por: Aschman, Tom, et al.
Publicado: (2021)

Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination
por: Liang, Boyun, et al.
Publicado: (2022)

Cellular and Humoral Responses from Sars-Cov-2 Specific CD45RA- Memory T Cells from Convalescent and Naive Donors. Clinical Application As an Adoptive Cell Therapy for COVID-19
por: Sanz, Karima AL-Akioui, et al.
Publicado: (2022)

Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
por: Hasan, Amal, et al.
Publicado: (2021)

Humoral and cellular response to the COVID-19 vaccine in immunocompromised children
por: Morgans, Heather A., et al.
Publicado: (2022)

Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature
por: Delgado-Fernández, Marcial, et al.
Publicado: (2022)

Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature
por: Delgado-Fernández, Marcial, et al.
Publicado: (2022)

SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
por: Wu, Jun, et al.
Publicado: (2021)

A 1-year longitudinal study on COVID-19 convalescents reveals persistence of anti-SARS-CoV-2 humoral and cellular immunity
por: Li, Yang, et al.
Publicado: (2022)

Specific T-cell responses for guiding treatment with convalescent plasma in severe COVID-19 and humoral immunodeficiency: a case report
por: Nyström, Katarina, et al.
Publicado: (2022)

Acquisition of Humoral Immune Responses in Convalescent Japanese People with SARS-CoV-2 (COVID-19) Infection in 2021
por: Monzen, Koshiro, et al.
Publicado: (2023)

Humoral and cellular immune memory to four COVID-19 vaccines
por: Zhang, Zeli, et al.
Publicado: (2022)

Humoral Response in SARS-CoV-2 Convalescent Compared to Vaccinated Kidney Transplant Patients
por: Schimpf, Judith, et al.
Publicado: (2022)

Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients
por: Dewald, Felix, et al.
Publicado: (2023)

Prolonged humoral and cellular immunity in COVID-19-recovered patients()
por: Alsayb, May A., et al.
Publicado: (2021)

Humoral and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL
por: Sun, Clare, et al.
Publicado: (2021)

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2020)

Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort
por: Tegeler, Christian M., et al.
Publicado: (2022)

Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months
por: Zheng, Yang, et al.
Publicado: (2021)

HUMORAL ANTIBODIES AND RESISTANCE OF VACCINATED AND CONVALESCENT MONKEYS TO POLIOMYELITIS VIRUS
por: Sabin, Albert B., et al.
Publicado: (1936)

Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
por: Peng, Pai, et al.
Publicado: (2021)

Loss of Humoral and Cellular Immunity to Invasive Nontyphoidal Salmonella during Current or Convalescent Plasmodium falciparum Infection in Malawian Children
por: Nyirenda, Tonney S., et al.
Publicado: (2017)

Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
por: Paniskaki, Krystallenia, et al.
Publicado: (2023)

The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients
por: Smits, Veronique A.J., et al.
Publicado: (2021)

COVID‐19 Alpha Variant (B.1.1.7): Humoral, memory B and T cells in COVID‐19 pediatric convalescents
por: Gurevich, Michael, et al.
Publicado: (2022)

SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
por: Geers, Daryl, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6v8iaa8nmre1iieio52ua65734